News

Olema Oncology Highlights Investor Conference Participation Plans

Olema Oncology Highlights Investor Conference Participation Plans

Olema Oncology's Upcoming Investor Conference Engagements

Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a pioneering clinical-stage biopharmaceutical firm, is dedicated to innovating targeted therapies aimed at treating breast cancer effectively. The company has announced its presence at several notable investor conferences. These conferences present a remarkable opportunity for Olema to share its recent developments and engage with the investment community.

Key Investor Conferences

Olema will participate in the renowned H.C. Wainwright 3rd Annual BioConnect Investor Conference, scheduled for Tuesday at 4:30 p.m. ET. This event will be a fireside chat format, taking place in New York City. During this engagement, executives will share insights about the company's pioneering efforts in breast cancer treatment and discuss its strategic vision for the future.

Another significant event is the T.D. Cowen 6th Annual Oncology Innovation Summit, set for the following week on Tuesday at 5 p.m. ET. This virtual summit will also feature a fireside chat, allowing Olema to connect with investors and industry leaders remotely. The discussions are anticipated to focus on the innovative clinical trials Olema is conducting and their potential impact on the field of oncology.

Webcast Access and Recording Availability

Live webcasts and recordings of both presentations will be made available to the public, contingent upon permissions from the event hosts. Interested individuals can find these valuable resources located in the Events and Presentations section of Olema’s investor relations website. This accessibility highlights Olema's commitment to transparency and engagement with its stakeholders.

About Olema Oncology

At the heart of Olema Oncology's mission is its commitment to transforming the standard of care for patients afflicted with breast cancer and other endocrine-driven cancers. The company is advancing a robust pipeline of innovative therapies, capitalizing on its profound understanding of nuclear receptors and resistance mechanisms in cancer treatment.

One of Olema's flagship candidates, palazestrant (OP-1250), is notable for being a proprietary, orally available complete estrogen receptor (ER) antagonist and a selective ER degrader (SERD). Currently, it is undergoing evaluation in the Phase 3 clinical trial known as OPERA-01. Additionally, Olema is progressing the development of a potent KAT6 inhibitor called OP-3136, which is hoped to contribute significantly to cancer management.

Headquartered in San Francisco, Olema also has operations in Cambridge, Massachusetts, reflecting its expansive reach in advancing biopharmaceutical innovations. For those eager to learn more about Olema's pipeline and initiatives, further details can be found on their official website.

Contact Information for Media and Investor Relations

For inquiries, Courtney O’Konek serves as the Vice President of Corporate Communications at Olema Oncology. Interested parties can reach out via email at media@olema.com to receive further information or clarification regarding Olema's research and investor relations.

Frequently Asked Questions

What conferences is Olema Oncology participating in?

Olema Oncology will participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference and the T.D. Cowen 6th Annual Oncology Innovation Summit.

What is Olema Oncology known for?

Olema Oncology is focused on developing targeted therapies for breast cancer and other endocrine-driven cancers, with a commitment to improving patient outcomes.

Where can I find recordings of Olema's presentations?

Recordings of Olema's conference presentations will be available in the Events and Presentations section of Olema’s investor relations website.

What is palazestrant (OP-1250)?

Palazestrant (OP-1250) is an orally available estrogen receptor antagonist and selective estrogen receptor degrader currently in a Phase 3 clinical trial.

How can I contact Olema Oncology for more information?

You can reach out to Courtney O’Konek, Vice President of Corporate Communications, at media@olema.com for inquiries regarding corporate communication and investor relations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Kobold Press Explores Roleplaying as Literacy Tool

Updated Category News Views 5

Gaming Illuminates Pathways to Literacy and Community Trust me, when an indie game publisher like Kobold Press makes waves, it's worth paying attention. They've carved a niche in the roleplaying world by marrying traditional game elements with valuable educational tools. The thrill of the game goes beyond rolling dice; it's a ticket to improving literacy, arithmetic, and...

Continue Reading
No Dogs Left Behind Marks Decade of Life-Saving Work

Updated Category News Views 4

A Decade of Dedication Some stories out there bring a much-needed shine to the otherwise relentless grind, and this is one of those rare gems. No Dogs Left Behind (NDLB) is celebrating a monumental milestone: ten years into their mission, they've crossed the incredible threshold of saving over 10,000 dogs from the clutches of slaughterhouses in East Asia. The nonprofit...

Continue Reading
Arizona Voters Demand Clear Plans for 2026 Election

Updated Category News Views 3

A Shift in Voter Expectations: Clear Actions Needed Arizona voters have spoken, and they aren't looking for the same old political song and dance anymore. They crave something meatier—action, not just words. Heading into the 2026 general election, folks in the Grand Canyon State are demanding concrete solutions and straightforward answers from those who seek to lead...

Continue Reading
Buffett Steps Down, New Faces at Berkshire Hathaway

Updated Category News Views 6

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

Continue Reading
Chattanooga: A New Epicenter for Quantum Computing

Updated Category News Views 4

Quantum Leap: Chattanooga's Bold Move So Chattanooga’s making waves again, folks. EPB just unveiled its new big shot, the IonQ Forte Enterprise quantum computer. That's right, they’ve slapped a commercial quantum computer and a networking hub together, right here in this Tennessee city. Is this a tech haven or what? Not to mention, it’s the first in America. A New...

Continue Reading
ETERC's Ele Aims to Revolutionize STEM Education for All

Updated Category News Views 6

The AI Mentor Battleground in Education Ever found yourself wondering how public schools could step up their game without dumping money down the tech rabbit hole? ETERC’s latest push with Ele may just be a game-changer for them. We're not talking about your run-of-the-mill chatbot regurgitating facts from the internet—this is an AI tricked out for personalized...

Continue Reading
Vetology Reinvents AI Models for Veterinary Radiology

Updated Category News Views 6

Revamping AI in Veterinary Practices Out there in San Diego, Vetology's been rolling up its sleeves and getting down to brass tacks with a complete do-over of their AI classifiers. They’ve rebuilt all 94 of them, every last one, on a brand-new architecture. No small task, this overhaul stretched from June to August and it wasn't just paint and polish but a whole new...

Continue Reading
Mental Health Day Celebrations Set for October in NYC

Updated Category News Views 7

Mental Health Steals the October Spotlight In the bustling streets of New York City, October is about to get a mental health makeover. Project Healthy Minds is putting the pedal to the metal with their fourth annual World Mental Health Day Gala on October 8th, followed by the world’s largest mental health festival on October 10th. These events, held at Spring Studios,...

Continue Reading
Bascom's Strategic Play on a Dallas Apartment Deal

Updated Category News Views 8

Unpacking Bascom's Jasmine Acquisition In a market that's been more slippery than a greased pig, Bascom Group's move buying up Jasmine Apartments is capturing some eyes. Situated in North Dallas, this 370-unit complex ain't just another brick in the wall—it's Bascom's 42nd entry into Texas, reinforcing their knack for sniffing out deals others might tiptoe around,...

Continue Reading
FOSSI Opens 2027 Applications for Future STEM Leaders

Updated Category News Views 3

Paving Pathways in the Chemical Industry There's something brewing that's got me eyeing the future with cautious optimism, and it doesn't involve hedge funds or earnings reports. It's the Future of STEM Scholars Initiative (FOSSI) playing its cards just right, planting seeds for tomorrow's innovators. This puppy opened the gates for 2027 applications, and for young brains...

Continue Reading

Top 5 Most Recently Viewed Articles

China's Economic Growth Faces Reality Amid Ongoing Challenges

Updated Category News Views 285

China's Economic Growth: A Closer Look China recently announced its economy grew by 5%, meeting its government's expectations. However, this growth is uneven; many citizens feel as if their living standards are declining. The nation has shown impressive industrial and export gains but is struggling to translate these into benefits for everyday consumers. The Potential for...

Continue Reading
Celebrities Celebrate at GBK's Annual Luxury Lounge Event

Updated Category News Views 356

Highlights from GBK's Annual Luxury Lounge Celebration Set against the glamorous backdrop of The Sun Rose Hotel on the famed Sunset Strip, this year's GBK's Luxury Lounge was a dazzling affair. Guests indulged in an extraordinary gifting experience, featuring some of the season's most luxurious items and unforgettable trips. The lounge, designed to honor television's...

Continue Reading
Netflix Earnings Outlook: Ad Plans and Pricing Strategies

Updated Category News Views 136

Netflix Earnings Outlook: Ad Plans and Pricing Strategies As Netflix Inc (NASDAQ: NFLX) approaches its third-quarter financial results, the focus shifts toward the potential impact of its ad-supported plan on revenue growth. The company is poised to unveil its strategies, moving the narrative from mere subscriber counts to long-term advertising opportunities when it...

Continue Reading
The Future of Wearable Technology: Innovations and Trends Ahead

Updated Category News Views 545

Wearable Technology Market Anticipates Remarkable Growth The global wearable technology market is poised for explosive growth, with projections indicating a valuation of US$ 885.65 billion by 2033, a substantial increase from US$ 218.27 billion in 2024. This impressive rise represents a compound annual growth rate (CAGR) of 16.84% over the forecast period from 2025 to...

Continue Reading
Understanding the Financial Impact of Opioid Use Disorder

Updated Category News Views 164

Opioid Use Disorder: A Growing Concern Opioid use disorder (OUD) has become a pressing issue in recent years, burdening taxpayers and local communities with substantial costs. According to compelling research, states and local governments allocate over $94 billion each year towards addressing the consequences of opioid misuse. This staggering figure underscores the urgent...

Continue Reading